• 1
    Burroughs AK. Pharmacological treatment of acute variceal bleeding. Digestion 1998; 59(Suppl. 2): 2836.
  • 2
    Lebrec D. Hemodynamic effects of terlipressin (Glypressin) in patients with cirrhosis. In: Lebrec, D, Blei, AT, eds. Vasopressin Analogs and Portal Hypertension. Paris: John Libbey Eurotext, 1987: 10512.
  • 3
    Escorsell A, Bandi JC, Moitinho E, et al. Time profile of haemodynamic effects of terlipressin in portal hypertension. J Hepatol 1997; 26: 6217.
  • 4
    Douglas JG, Forrest JA, Prowse CV, Cash JD, Finlayson ND. Effects of lysine vasopressin and glypressin on the fibrinolytic system in cirrhosis. Gut 1979; 20: 5657.
  • 5
    De Franchis R. Updating consensus in portal hypertension. Report of the Baveno III consensus workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000; 33: 86452.
  • 6
    Jadad AR. Meta-analysis of Randomized Clinical Trials in Pain Relief. PhD Thesis, University of Oxford, 1994.
  • 7
    Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 112.
  • 8
    Moher D, Pham B, Jones A, et al. Does quality of reports of randomized trials affect estimates of intervention efficacy reported in meta-analysis? Lancet 1998; 352: 60913.
  • 9
    Petitti DB. Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis. New York: Oxford University Press, 1994.
  • 10
    Aracidiacono R, Biraghi M, Bonomo GM, Fiaccadori F. Randomized controlled trial with terlipressin in cirrhotic patients with rebleeding esophageal varices: effects on precocious rebleeding and mortality rates. Curr Ther Res 1992; 52: 18694.
  • 11
    Fiaccadori F, Pedretti G, Biraghi M, Arcidiacono R. Terlypressin and endoscopic sclerotherapy control variceal bleeding and prevent early rebleeding in cirrhotic patients. Curr Ther Res Clin Exp 1993; 54: 51928.
  • 12
    Chang TT, Lee FY, Tsai YT, et al. A randomized controlled study of low-dose and high-dose terlipressin in the control of acute esophageal variceal hemorrhage. J Gastroenterol Hepatol 1991; 6: 4814.
  • 13
    De Franchis R, Arcidiacono PG, Carpinelli L, Andreoni B, Cestari L, Brunati S. Randomized controlled trial of desmopressin plus terlipressin vs. terlipressin alone for the treatment of acute variceal hemorrhage in cirrhotic patients: a multicenter, double-blind study. Hepatology 1993; 18: 11027.
  • 14
    Chen SC, Lin ZY, Lu SN, Chuang WL, Hsieh MY, Wang LY. The effect of pitressin and glypressin in variceal bleeding − a preliminary clinical trial. Kao-Hsiung i Hsueh Ko Hsueh Tsa Chih[Kaohsiung J Med Sci]1990; 6: 5515.
  • 15
    Heygere FD, Burroughs AK, Sherlock S, McIntyre N. Prospective evaluation of glypressin for variceal bleeding in cirrhotics. Gut 1986; 27: A1247(Abstract).
  • 16
    Olivero S, Mao P, Rozzio G, Foco A, Enrichens F, Bouzari H. Clinical experiment with glypressin in hemorrhage due to esophageal varices[Italian]. Minerva Dietologica e Gastroenterologica 1986; 32: 314.
  • 17
    Vosmik J, Jedlicka K, Mulder JL, Cort JH. Action of the triglycyl hormonogen of vasopressin (glypressin) in patients with liver cirrhosis and bleeding esophageal varices. Gastroenterology 1977; 72(4 Part 1): 6059.
  • 18
    Palazzi A, Laurenzi F, Tiburzi C, Ottaviani O. Usefulness of supplemental treatment with glypressin during the eradication phase of esophageal varices using endoscopic sclerotherapy[Italian]. Minerva Dietologica e Gastroenterologica 1989; 35: 25760.
  • 19
    Campisi C, Padula P, Peressini A, Boccardo F, Biraghi M, Casaccia M. Upper digestive hemorrhage. Comparison of terlipressin and octreotide[Italian]. Minerva Chirurgica 1993; 48: 10916.
  • 20
    Silk DBA, Mitchell KJ, MacDougal BDR, Williams R. Medical management of patients with portal hypertension bleeding from esophageal varices. In: Williams, R, Cantani, L, eds. Recenti Progressi Epatologi. Milan: Casa Editrice, 1979: 514.
  • 21
    Pauwels A, Florent C, Desaint B, Van Guivarch PH, Levy VG. Terlipressin and somatostatin in the treatment of hemorrhages from rupture of esophageal varices (letter)[French]. Gastroenterologie Clinique Biologique 1994; 18: 3889.
  • 22
    Freeman JG, Cobden I, Record CO. Placebo-controlled trial of terlipressin (glypressin) in the management of acute variceal bleeding. J Clin Gastroenterol 1989; 11: 5860.
  • 23
    Levacher S, Letoumelin P, Pateron D, Blaise M, Lapandry C, Pourriat JL. Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet 1995; 346: 8658.
  • 24
    Soderlund C, Magnusson I, Torngren S, Lundell L. Terlipressin (triglycyl-lysine vasopressin) controls acute bleeding esophageal varices. A double-blind, randomized, placebo-controlled trial. Scand J Gastroenterol 1990; 25: 62230.
  • 25
    Walker S, Stiehl A, Raedsch R, Kommerell B. Terlipressin in bleeding esophageal varices: a placebo-controlled, double-blind study. Hepatology 1986; 6: 1125.
  • 26
    Brunati X, Ceriani R, Curioni R, Brunelli L, Repaci G, Morini L. Sclerotherapy alone vs scherotherapy plus terlipressin vs sclerotherapy plus octreotide in the treatment of acute variceal hemorrhage. Hepatology 1996; 24(4 part 2): 207A.
  • 27
    Patch D, Caplin M, Greenslade L, Burroughs A. Randomized double blind controlled trial of 5 day terlipressin vs placebo in acute variceal hemorrhage. J Hepatol 1999; 30(Suppl. 1): 55.
  • 28
    Colin R, Giuli N, Czernichow P, et al. Prospective comparison of glypressin, tamponade and their association in the treatment of bleeding esophageal varices. In: Lebrec, D, Blei, AT, eds. Vasopressin Analogs and Portal Hypertension. Paris: John Libbey Eurotext, 1987: 14953.
  • 29
    Fort E, Sautereau D, Silvain C, Ingrand P, Pillegand B, Beauchant M. A randomized trial of terlipressin plus nitroglycerin vs. balloon tamponade in the control of acute variceal hemorrhage. Hepatology 1990; 11: 67881.
  • 30
    Garcia-Compean D, Blanc P, Bories JM, Michel J, Desprez D, Pageaux GP. Treatment of active gastroesophageal variceal bleeding with terlipressin or hemostatic balloon in patients with cirrhosis: a randomized controlled trial. Arch Med Res 1997; 28: 2415.
  • 31
    Escorsell A, Ruiz del Arbol L, Planas R, Albillos A, Banares R, Bosch J. Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: the TEST study. Hepatology 2000; 32: 4716.
  • 32
    Pedretti G, Elia G, Calzetti C, Magnani G, Fiaccadori F. Octreotide versus terlypressin in acute variceal hemorrhage in liver cirrhosis. Emergency control and prevention of early rebleeding. Clin Invest 1994; 72: 6539.
  • 33
    Silvain C, Carpentier S, Sautereau D, et al. Terlipressin plus transdermal nitroglycerin vs. octreotide in the control of acute bleeding from esophageal varices: a multicenter randomized trial. Hepatology 1993; 18: 615.
  • 34
    Feu F, Ruiz del Arbol L, Banares R, Planas R, Bosch J. Double-blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Gastroenterology 1996; 111: 12919.
  • 35
    Walker S, Kreichgauer HP, Bode JC. Terlipressin (glypressin) versus somatostatin in the treatment of bleeding esophageal varices – final report of a placebo-controlled, double-blind study. Z Fur Gastroenterologie 1996; 34: 6928.
  • 36
    Freeman JG, Cobden I, Lishman AH, Record CO. Controlled trial of terlipressin (‘Glypressin’) versus vasopressin in the early treatment of esophageal varices. Lancet 1982; 2: 668.
  • 37
    Desaint B, Florent C, Levy VG. A randomized trial of triglycyl-lysine vasopressin versus lysine vasopressin in active cirrhotic variceal hemorrhage. In: Lebrec, D, Blei, AT, eds. Vasopressin Analogs and Portal Hypertension. Paris: John Libbey Eurotext, 1987: 1557.
  • 38
    Lee YF, Tsay YT, Lai KH, Lay CS, Chang TT, Malik U. A randomized controlled study of triglycyl-vasopressin and vasopressin plus nitrglycerin in the control of acute esophageal variceal hemorrhage. Chinese J Gastroenterol 1988; 5: 1318.
  • 39
    Chiu KW, Sheen IS, Liaw YF. A controlled study of glypressin versus vasopressin in the control of bleeding from esophageal varices. J Gastroenterol Hepatol 1990; 5: 54953.
  • 40
    D'Amico G, Traina M, Vizzini G, Tine F, Politi F, Montalbano L. Terlipressin or vasopressin plus transdermal nitroglycerin in a treatment strategy for digestive bleeding in cirrhosis. A randomized clinical trial. J Hepatol 1994; 20: 20612.
  • 41
    Sharara AI, Rockey DC. Gastroesophageal variceal hemorrhage. N Eng J Med 2001; 345(9): 66981.
  • 42
    D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995; 22(1): 33254.
  • 43
    Fano M, Biraghi M. Terlipressina (Glipressina) nel sanguinamento da varici esofagee: studio di metanalisi. Giorn Ital End Dig 1994; 17: 13541.
  • 44
    D'Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Sem Liver Dis 1999; 19(4): 475505.
  • 45
    Gotzsche PC. Somatostatin or octreotide for acute bleeding esophageal varices. The Cochrane Database of Systematic Reviews 2000; Issue 2.
  • 46
    Corley DA, Cello JP, Adkisson W, Ko WF, Kerlikowske K. Octreotide for acute esophageal variceal bleeding: a meta-analysis. Gastroenterology 2001; 120(4): 94654.
  • 47
    Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. J Am Med Assoc 1995; 273(5): 40812.
  • 48
    Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. Ann Intern Med 1995; 123: 2807.